Jul 8, 2021
In this episode, Julie Rubinstein, MBA, discusses her journey into the cancer space, the importance of personalized medicine and how her father’s cancer diagnosis played a role in her career.
Julie Rubinstein, MBA, is the president of Adaptive Biotechnologies. She currently oversees Life Sciences Research, Clinical Diagnostics, Drug Discovery, Corporate Marketing and Business Development functions.
We’d love to hear from you! Send your comments/questions to Dr. Jain at email@example.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Rubinstein can be reached via email at firstname.lastname@example.org.
Disclosures: Jain reports she is a paid freelance writer for Lippincott. Rubinstein is the president of Adaptive Biotechnologies and has stock and other ownership interests in the company.